CAPR - Capricor Therapeutics, Inc.
NEXT EARNINGS:
Mar 18, 2026
(in 21 days)
EPS Est: $-0.51
|
Rev Est: $525000
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.71
DETAILS
HIGH:
$60.00
LOW:
$13.00
MEDIAN:
$50.00
CONSENSUS:
$45.71
UPSIDE:
63.78%
Market Cap:
1.28B
Volume:
779,312
Avg Volume:
2,778,573
52 Week Range:
4.3-40.37
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.40
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
160
IPO Date:
2007-02-13
EPS (TTM):
-1.15
P/E Ratio:
-12.01
Revenue (TTM):
22.27M
Total Assets:
170.48M
Total Debt:
1.45M
Cash & Equiv:
11.29M
Rev Growth (5Y):
85.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-28.5%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.54 | $-0.54 | 0.0% | — | $600000 | — |
| 2025-05-13 | $-0.53 | $-0.33 | -60.6% | — | $3.2M | — |
| 2025-03-19 | $-0.16 | $-0.31 | +48.4% | $11.1M | $5.5M | +102.4% |
| 2024-11-13 | $-0.38 | $-0.34 | -11.8% | $2.3M | $9.9M | -77.1% |
| 2024-08-07 | $-0.35 | $-0.32 | -9.4% | $4.0M | $3.6M | +10.9% |
| 2024-05-13 | $-0.31 | $-0.11 | -181.8% | $4.9M | $9.7M | -49.4% |
| 2024-02-29 | $-0.02 | $-0.23 | +91.3% | $12.1M | $10.6M | +14.0% |
| 2023-11-14 | $-0.25 | $-0.27 | +7.4% | $6.2M | $10.9M | -43.2% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.27M | 25.18M | 2.55M | 244,898 | 310,250 | 1.01M | 1.67M | 2.67M | 3.19M | 3.78M | 4.17M | 503,233 |
| Net Income | (40.47M) | (22.29M) | (29.02M) | (20.02M) | (13.66M) | (7.64M) | (15.19M) | 2.43M | (18.81M) | (12.86M) | (6.22M) | (8.89M) |
| EPS | -1.15 | -0.83 | -1.18 | -0.87 | -0.88 | -2.06 | -5.17 | 1.00 | -10.14 | -8.09 | -5.31 | -8.47 |
| Total Assets | 170.48M | 58.73M | 50.09M | 41.33M | 34.62M | 11.11M | 9.25M | 16.27M | 18.75M | 16.07M | 13.63M | 5.54M |
| Total Debt | 1.45M | 2.24M | 2.56M | 2.87M | 318,160 | 0 | 0 | 0 | 13.91M | 9.16M | 9.16M | 3.96M |
| Cash & Equivalents | 11.29M | 14.69M | 9.60M | 34.89M | 32.67M | 3.90M | 4.26M | 6.14M | 3.20M | 5.57M | 8.03M | 1.73M |
| Operating Cash Flow | (40.00M) | (25.60M) | 4.92M | (16.81M) | (10.05M) | (6.82M) | (13.86M) | (14.23M) | (15.80M) | (10.82M) | 958,562 | (6.14M) |
| Free Cash Flow | (41.53M) | (27.64M) | 1.56M | (18.01M) | (10.60M) | (6.82M) | (14.18M) | (14.26M) | (16.00M) | (10.97M) | 772,131 | (6.25M) |
| FCF per Share | -1.18 | -1.03 | 0.06 | -0.78 | -0.68 | -1.84 | -4.83 | -6.15 | -8.62 | -6.90 | 0.66 | -5.96 |
| Book Value | 145.46M | 22.60M | 11.79M | 31.37M | 28.20M | 6.84M | 4.62M | 11.23M | (4.00M) | (1.03M) | (6.25M) | (534,882) |
| Cash & ST Investments | 151.52M | 39.49M | 41.42M | 34.89M | 32.67M | 9.89M | 7.26M | 14.12M | 16.19M | 13.57M | 8.03M | 2.06M |
| ROC Equity | -0.28 | -0.99 | -2.46 | -0.64 | -0.48 | -1.12 | -3.29 | 0.22 | N/A | N/A | N/A | N/A |